Toshiba America Medical Systems has restructured its sales and marketing organization, creating a matrix system with a strategic focus on end users running across all imaging modalities, according to Scott Eaton, director of the imaging center market
Toshiba America Medical Systems has restructured its sales and marketing organization, creating a matrix system with a strategic focus on end users running across all imaging modalities, according to Scott Eaton, director of the imaging center market business for TAMS.
We have become focused on the way our customers are organized, he said.
Eaton was director of MRI business unit developmenta discontinued position.
Existing MR product managers have remained in place, taking on some of the responsibilities that had belonged to the modalitys business unit director. New sales specialists have been assigned to focus on imaging centers, which are the prime market for Toshibas Opart 0.35-tesla superconductive open MRI scanner.
Charles Corogenes will provide direction to TAMS sales and marketing efforts for imaging products aimed at hospitals as director of the Integrated Delivery Network (IDN)/Group Purchasing Organization segment. Don Volz, former director of the x-ray business unit, has been named director of the cardiology segment.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.